Works matching IS 25233548 AND DT 2021 AND VI 41 AND IP 3

Results: 9

Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis.

Published in:

Cancer Communications, 2021, v. 41, n. 3, p. 275, doi. 10.1002/cac2.12150

By:

Yi, Jun Ho;
Kim, Seok Jin;
Yoon, Dok Hyun;
Suh, Cheolwon;
Chang, Myung Hee;
Yang, Deok Hwan;
Jo, Jae‐Cheol;
Hyun, Shin Young;
Eom, Hyeon‐Seok;
Lee, Jeong‐Ok;
Kwon, Ji Hyun;
Han, Sang Hoon;
Lee, Seung‐Shin;
Kwak, Jae‐Yong;
Kim, Se Hyung;
Kim, Dae Sik;
Lee, Ji Hyun;
Oh, Sung Yong;
Ryoo, Hun Mo;
Kim, Hyo Jung

Publication type:

Article

Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma?

Published in:

Cancer Communications, 2021, v. 41, n. 3, p. 273, doi. 10.1002/cac2.12148

By:

Young, Ken H.

Publication type:

Article

Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4.

Published in:

Cancer Communications, 2021, v. 41, n. 3, p. 258, doi. 10.1002/cac2.12141

By:

Guo, Ting;
Bai, Yan‐Hua;
Cheng, Xiao‐Jing;
Han, Hai‐Bo;
Du, Hong;
Hu, Ying;
Jia, Shu‐Qin;
Xing, Xiao‐Fang;
Ji, Jia‐Fu

Publication type:

Article

EMT‐associated microRNAs and their roles in cancer stemness and drug resistance.

Published in:

Cancer Communications, 2021, v. 41, n. 3, p. 199, doi. 10.1002/cac2.12138

By:

Pan, Guangtao;
Liu, Yuhan;
Shang, Luorui;
Zhou, Fangyuan;
Yang, Shenglan

Publication type:

Article

Co‐occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.

Published in:

Cancer Communications, 2021, v. 41, n. 3, p. 218, doi. 10.1002/cac2.12134

By:

Ferrer‐Avargues, Rosario;
Castillejo, María Isabel;
Dámaso, Estela;
Díez‐Obrero, Virginia;
Garrigos, Noemí;
Molina, Tatiana;
Codoñer‐Alejos, Alan;
Segura, Ángel;
Sánchez‐Heras, Ana Beatriz;
Castillejo, Adela;
Soto, José Luis

Publication type:

Article

BAALC‐AS1/G3BP2/c‐Myc feedback loop promotes cell proliferation in esophageal squamous cell carcinoma.

Published in:

Cancer Communications, 2021, v. 41, n. 3, p. 240, doi. 10.1002/cac2.12127

By:

Zhang, Hongyue;
Wang, Yan;
Zhang, Weimin;
Wu, Qingnan;
Fan, Jiawen;
Zhan, Qimin

Publication type:

Article

Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China.

Published in:

Cancer Communications, 2021, v. 41, n. 3, p. 229, doi. 10.1002/cac2.12126

By:

Wang, Shuo;
Wang, Li;
Hu, Jianda;
Qian, Wenbin;
Zhang, Xi;
Hu, Yu;
Zhu, Qi;
Chen, Bobin;
Wu, Depei;
Chang, Chung‐Chou H.;
Xu, Pengpeng;
Zheng, Xiaoyun;
Wei, Juying;
Liu, Yao;
Cui, Guohui;
Tang, Yong;
Ma, Yan;
Huang, Haiwen;
Yi, Hongmei;
Zhao, Weili

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2021, v. 41, n. 3, p. 197, doi. 10.1002/cac2.12055
Publication type:: Article

Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome.

Published in:

Cancer Communications, 2021, v. 41, n. 3, p. 279, doi. 10.1002/cac2.12136

By:

Ju, Wu‐tong;
Liu, Ying;
Wang, Li‐zhen;
Li, Jiang;
Ren, Guo‐xing;
Sun, Jian;
Tu, Wen‐yong;
Hu, Yong‐jie;
Ji, Tong;
Yang, Wen‐jun;
Li, Jun;
He, Yue;
Wang, Yan‐an;
Zhang, Chen‐ping;
Zhong, Lai‐ping;
Zhang, Zhi‐yuan

Publication type:

Article